|
nasdaq:grfs
|
https://www.indeed.com/cmp/grifols
|
Aug 29th, 2022 12:00AM
|
Open
|
Grifols
|
|
Healthcare
|
Grifols is a global healthcare company which, since its foundation in Barcelona in 1909, has been working to improve the health and well-being of people all over the world. Our four divisions - Bioscience, Diagnostic, Hospital and Bio Supplies - develop, produce and market innovative medicines, solutions and services in more than 100 countries and regions.
As a pioneer in the blood products industry, we are one of the largest plasma companies, with a growing network of donation centers around the world. With the plasma we obtain, we produce essential medicines to treat chronic, rare and sometimes life-threatening diseases. As a recognized leader in transfusion medicine, we have a comprehensive portfolio of solutions designed to ensure safety from donation to transfusion. In addition, we provide hospitals, pharmacies and healthcare professionals with diagnostic tools and services that help improve the detection and treatment of diseases, promoting specialized and efficient care.
Our commitment to science and people drives us to continue innovating and exploring the potential of plasma treatments to respond to the main health challenges facing our society.
With a workforce of over 24,000 employees in more than 30 countries and regions, Grifols is committed to a sustainable business model and is a benchmark for continuous innovation, quality, safety and ethical leadership in the sector. Our activity has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth.
|
RRv1_1B_5B
|
Barcelona, SP
|
Raimon Grifols and Victor Grifols Deu
|
|
|
3.00
|
52.0
|
56.0
|
62.0
|
52.0
|
53.0
|
49.0
|
46.0
|
58.0
|
47.0
|
49.0
|
|
56.0
|
57.0
|
1463.0
|
2728
|
2700
|
2.80
|
3.30
|
2.90
|
2.60
|
2.70
|
583.00
|
About two weeks
|
639.00
|
EASY
|
602.00
|
AVERAGE
|
|
|
|
Aug 29th, 2022 12:02PM
|
Aug 29th, 2022 12:02PM
|
Grifols
|
|
|
|
nasdaq:grfs
|
https://www.indeed.com/cmp/biotest-pharmaceuticals-corporation
|
Aug 29th, 2022 12:00AM
|
Open
|
BPC Plasma Inc
|
|
Pharmaceutical & Biotechnology
|
|
RRv1_100M_500M
|
Boca Raton, FL
|
|
|
|
3.20
|
52.0
|
57.0
|
62.0
|
56.0
|
56.0
|
53.0
|
52.0
|
62.0
|
48.0
|
52.0
|
53.0
|
57.0
|
63.0
|
68.0
|
195.00
|
195.00
|
2.90
|
3.30
|
2.80
|
2.80
|
3.00
|
34.00
|
About a week
|
38.00
|
MEDIUM
|
35.00
|
AVERAGE
|
|
|
|
Aug 29th, 2022 12:02PM
|
Aug 29th, 2022 12:02PM
|
Grifols
|
|
|
|
nasdaq:grfs
|
https://www.indeed.com/cmp/biotest-pharmaceuticals-corporation
|
Aug 28th, 2022 12:00AM
|
Open
|
BPC Plasma Inc
|
|
Pharmaceutical & Biotechnology
|
|
RRv1_100M_500M
|
Boca Raton, FL
|
|
|
|
3.20
|
52.0
|
57.0
|
62.0
|
56.0
|
56.0
|
53.0
|
52.0
|
62.0
|
48.0
|
52.0
|
53.0
|
57.0
|
63.0
|
68.0
|
195.00
|
195.00
|
2.90
|
3.30
|
2.80
|
2.80
|
3.00
|
34.00
|
About a week
|
38.00
|
MEDIUM
|
35.00
|
AVERAGE
|
|
|
|
Aug 28th, 2022 05:01AM
|
Aug 28th, 2022 05:01AM
|
Grifols
|
|
|
|
nasdaq:grfs
|
https://www.indeed.com/cmp/grifols
|
Aug 28th, 2022 12:00AM
|
Open
|
Grifols
|
|
Healthcare
|
Grifols is a global healthcare company which, since its foundation in Barcelona in 1909, has been working to improve the health and well-being of people all over the world. Our four divisions - Bioscience, Diagnostic, Hospital and Bio Supplies - develop, produce and market innovative medicines, solutions and services in more than 100 countries and regions.
As a pioneer in the blood products industry, we are one of the largest plasma companies, with a growing network of donation centers around the world. With the plasma we obtain, we produce essential medicines to treat chronic, rare and sometimes life-threatening diseases. As a recognized leader in transfusion medicine, we have a comprehensive portfolio of solutions designed to ensure safety from donation to transfusion. In addition, we provide hospitals, pharmacies and healthcare professionals with diagnostic tools and services that help improve the detection and treatment of diseases, promoting specialized and efficient care.
Our commitment to science and people drives us to continue innovating and exploring the potential of plasma treatments to respond to the main health challenges facing our society.
With a workforce of over 24,000 employees in more than 30 countries and regions, Grifols is committed to a sustainable business model and is a benchmark for continuous innovation, quality, safety and ethical leadership in the sector. Our activity has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth.
|
RRv1_1B_5B
|
Barcelona, SP
|
Raimon Grifols and Victor Grifols Deu
|
|
|
3.00
|
52.0
|
56.0
|
62.0
|
52.0
|
53.0
|
49.0
|
46.0
|
58.0
|
47.0
|
49.0
|
49.0
|
56.0
|
57.0
|
1462.0
|
2728
|
2700
|
2.80
|
3.30
|
2.90
|
2.60
|
2.70
|
583.00
|
About two weeks
|
639.00
|
EASY
|
602.00
|
AVERAGE
|
|
|
|
Aug 28th, 2022 05:01AM
|
Aug 28th, 2022 05:01AM
|
Grifols
|
|
|
|
nasdaq:grfs
|
https://www.indeed.com/cmp/biotest-pharmaceuticals-corporation
|
Aug 27th, 2022 12:00AM
|
Open
|
BPC Plasma Inc
|
|
Pharmaceutical & Biotechnology
|
|
RRv1_100M_500M
|
Boca Raton, FL
|
|
|
|
3.20
|
52.0
|
57.0
|
62.0
|
56.0
|
56.0
|
53.0
|
52.0
|
62.0
|
48.0
|
52.0
|
53.0
|
57.0
|
63.0
|
68.0
|
195.00
|
195.00
|
2.90
|
3.30
|
2.80
|
2.80
|
3.00
|
34.00
|
About a week
|
38.00
|
MEDIUM
|
35.00
|
AVERAGE
|
|
|
|
Aug 27th, 2022 04:20AM
|
Aug 27th, 2022 04:20AM
|
Grifols
|
|
|
|
nasdaq:grfs
|
https://www.indeed.com/cmp/grifols
|
Aug 27th, 2022 12:00AM
|
Open
|
Grifols
|
|
Healthcare
|
Grifols is a global healthcare company which, since its foundation in Barcelona in 1909, has been working to improve the health and well-being of people all over the world. Our four divisions - Bioscience, Diagnostic, Hospital and Bio Supplies - develop, produce and market innovative medicines, solutions and services in more than 100 countries and regions.
As a pioneer in the blood products industry, we are one of the largest plasma companies, with a growing network of donation centers around the world. With the plasma we obtain, we produce essential medicines to treat chronic, rare and sometimes life-threatening diseases. As a recognized leader in transfusion medicine, we have a comprehensive portfolio of solutions designed to ensure safety from donation to transfusion. In addition, we provide hospitals, pharmacies and healthcare professionals with diagnostic tools and services that help improve the detection and treatment of diseases, promoting specialized and efficient care.
Our commitment to science and people drives us to continue innovating and exploring the potential of plasma treatments to respond to the main health challenges facing our society.
With a workforce of over 24,000 employees in more than 30 countries and regions, Grifols is committed to a sustainable business model and is a benchmark for continuous innovation, quality, safety and ethical leadership in the sector. Our activity has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth.
|
RRv1_1B_5B
|
Barcelona, SP
|
Raimon Grifols and Victor Grifols Deu
|
|
|
3.00
|
52.0
|
56.0
|
62.0
|
52.0
|
53.0
|
49.0
|
46.0
|
58.0
|
47.0
|
49.0
|
49.0
|
56.0
|
57.0
|
1462.0
|
2728
|
2700
|
2.80
|
3.30
|
2.90
|
2.60
|
2.70
|
583.00
|
About two weeks
|
639.00
|
EASY
|
602.00
|
AVERAGE
|
|
|
|
Aug 27th, 2022 04:20AM
|
Aug 27th, 2022 04:20AM
|
Grifols
|
|
|
|
nasdaq:grfs
|
https://www.indeed.com/cmp/grifols
|
Aug 25th, 2022 12:00AM
|
Open
|
Grifols
|
|
Healthcare
|
Grifols is a global healthcare company which, since its foundation in Barcelona in 1909, has been working to improve the health and well-being of people all over the world. Our four divisions - Bioscience, Diagnostic, Hospital and Bio Supplies - develop, produce and market innovative medicines, solutions and services in more than 100 countries and regions.
As a pioneer in the blood products industry, we are one of the largest plasma companies, with a growing network of donation centers around the world. With the plasma we obtain, we produce essential medicines to treat chronic, rare and sometimes life-threatening diseases. As a recognized leader in transfusion medicine, we have a comprehensive portfolio of solutions designed to ensure safety from donation to transfusion. In addition, we provide hospitals, pharmacies and healthcare professionals with diagnostic tools and services that help improve the detection and treatment of diseases, promoting specialized and efficient care.
Our commitment to science and people drives us to continue innovating and exploring the potential of plasma treatments to respond to the main health challenges facing our society.
With a workforce of over 24,000 employees in more than 30 countries and regions, Grifols is committed to a sustainable business model and is a benchmark for continuous innovation, quality, safety and ethical leadership in the sector. Our activity has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth.
|
RRv1_1B_5B
|
Barcelona, SP
|
Raimon Grifols and Victor Grifols Deu
|
|
|
3.00
|
52.0
|
56.0
|
62.0
|
52.0
|
52.0
|
49.0
|
46.0
|
58.0
|
47.0
|
49.0
|
49.0
|
56.0
|
57.0
|
1460.0
|
2720
|
2700
|
2.80
|
3.30
|
2.90
|
2.60
|
2.70
|
581.00
|
About two weeks
|
637.00
|
EASY
|
602.00
|
AVERAGE
|
|
|
|
Aug 25th, 2022 09:00AM
|
Aug 25th, 2022 09:00AM
|
Grifols
|
|
|
|
nasdaq:grfs
|
https://www.indeed.com/cmp/biotest-pharmaceuticals-corporation
|
Aug 25th, 2022 12:00AM
|
Open
|
BPC Plasma Inc
|
|
Pharmaceutical & Biotechnology
|
|
RRv1_100M_500M
|
Boca Raton, FL
|
|
|
|
3.20
|
52.0
|
57.0
|
62.0
|
56.0
|
56.0
|
53.0
|
52.0
|
62.0
|
48.0
|
52.0
|
53.0
|
57.0
|
63.0
|
68.0
|
195.00
|
195.00
|
2.90
|
3.30
|
2.80
|
2.80
|
3.00
|
34.00
|
About a week
|
38.00
|
MEDIUM
|
35.00
|
AVERAGE
|
|
|
|
Aug 25th, 2022 09:00AM
|
Aug 25th, 2022 09:00AM
|
Grifols
|
|
|
|
nasdaq:grfs
|
https://www.indeed.com/cmp/grifols
|
Aug 23rd, 2022 12:00AM
|
Open
|
Grifols
|
|
Healthcare
|
Grifols is a global healthcare company which, since its foundation in Barcelona in 1909, has been working to improve the health and well-being of people all over the world. Our four divisions - Bioscience, Diagnostic, Hospital and Bio Supplies - develop, produce and market innovative medicines, solutions and services in more than 100 countries and regions.
As a pioneer in the blood products industry, we are one of the largest plasma companies, with a growing network of donation centers around the world. With the plasma we obtain, we produce essential medicines to treat chronic, rare and sometimes life-threatening diseases. As a recognized leader in transfusion medicine, we have a comprehensive portfolio of solutions designed to ensure safety from donation to transfusion. In addition, we provide hospitals, pharmacies and healthcare professionals with diagnostic tools and services that help improve the detection and treatment of diseases, promoting specialized and efficient care.
Our commitment to science and people drives us to continue innovating and exploring the potential of plasma treatments to respond to the main health challenges facing our society.
With a workforce of over 24,000 employees in more than 30 countries and regions, Grifols is committed to a sustainable business model and is a benchmark for continuous innovation, quality, safety and ethical leadership in the sector. Our activity has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth.
|
RRv1_1B_5B
|
Barcelona, SP
|
Raimon Grifols and Victor Grifols Deu
|
|
|
3.00
|
52.0
|
56.0
|
62.0
|
52.0
|
52.0
|
49.0
|
46.0
|
58.0
|
47.0
|
49.0
|
49.0
|
56.0
|
57.0
|
1460.0
|
2720
|
2700
|
2.80
|
3.30
|
2.90
|
2.60
|
2.70
|
578.00
|
About two weeks
|
634.00
|
EASY
|
600.00
|
AVERAGE
|
|
|
|
Aug 23rd, 2022 10:53AM
|
Aug 23rd, 2022 10:53AM
|
Grifols
|
|
|
|
nasdaq:grfs
|
https://www.indeed.com/cmp/biotest-pharmaceuticals-corporation
|
Aug 23rd, 2022 12:00AM
|
Open
|
BPC Plasma Inc
|
|
Pharmaceutical & Biotechnology
|
|
RRv1_100M_500M
|
Boca Raton, FL
|
|
|
|
3.20
|
52.0
|
57.0
|
62.0
|
56.0
|
56.0
|
53.0
|
52.0
|
62.0
|
48.0
|
52.0
|
53.0
|
57.0
|
63.0
|
68.0
|
195.00
|
195.00
|
2.90
|
3.30
|
2.80
|
2.80
|
3.00
|
34.00
|
About a week
|
38.00
|
MEDIUM
|
35.00
|
AVERAGE
|
|
|
|
Aug 23rd, 2022 10:53AM
|
Aug 23rd, 2022 10:53AM
|
Grifols
|
|
|